Financials in GBp. Standardized financial statements.
A compact view of how PureTech Health plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £4.76M | £4.32M | £750,000 | £2.09M | £9.98M | £8.34M | £8.69M | £16.37M | £650,000 | £4.43M |
| Revenue Growth? | +10.2% | +475.3% | -64.1% | -79.1% | +19.6% | -4.0% | -46.9% | +2418.6% | -85.3% | 0.0% |
| Cost of Revenue? | £3.42M | £0 | £93.66M | £152.43M | £110.47M | £0 | £85.85M | £77.40M | £71.03M | £41.20M |
| Gross Profit? | £1.34M | £4.32M | -£92.91M | -£136.81M | -£100.49M | £8.34M | -£77.16M | -£61.03M | -£70.39M | -£36.77M |
| Gross Margin? | +28.1% | +100.0% | -12387.3% | -6546.2% | -1007.0% | +100.0% | -888.1% | -372.8% | -10828.5% | -829.9% |
| Operating Expenses? | £101.93M | £140.41M | £53.29M | £60.99M | £57.20M | £127.87M | £144.09M | £120.39M | £116.07M | £78.36M |
| Operating Income? | -£100.59M | -£136.09M | -£146.20M | -£197.81M | -£150.28M | -£119.53M | -£135.40M | -£104.02M | -£115.42M | -£73.93M |
| EBITDA? | -£97.17M | £37.38M | -£17.68M | -£79.94M | -£46.95M | -£115.58M | £487.78M | -£65.27M | -£67.91M | -£77.39M |
| Income Before Tax | -£113.25M | £23.77M | -£36.10M | -£92.78M | -£58.95M | £18.97M | £478.47M | -£68.44M | -£70.71M | -£83.18M |
| Income Tax Expense | -£859,664 | -£4.01M | £30.52M | -£55.72M | £3.76M | £14.40M | £112.41M | £2.22M | -£14,000 | -£1.57M |
| Net Income? | -£112.04M | £53.51M | -£65.70M | -£50.35M | -£60.56M | £5.99M | £421.14M | -£70.66M | -£70.70M | -£48.79M |
| EPS? | £-0.47 | £0.20 | £-0.24 | £-0.18 | £-0.21 | £0.02 | £1.49 | £-0.26 | £-0.30 | £-0.21 |
| Diluted EPS? | £-0.47 | £0.20 | £-0.24 | £-0.18 | £-0.21 | £0.02 | £1.44 | £-0.26 | £-0.30 | £-0.21 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality